ZEPP
Get informed when a big investor buys or sells
+ FollowOvervalued by 205.9% based on the discounted cash flow analysis.
| Market cap | $67.17 Million |
|---|---|
| Enterprise Value | $729.59 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-283.04 |
| Beta | 1.78 |
| Outstanding Shares | 991,910 |
| P/E Ratio | -0.11 |
|---|---|
| PEG | -0.02 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 0.47 |
| Enterprise Value to EBIT | -4.51 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 1.88 |
| Debt to Equity | 1.03 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.1592▼ 82.67% |
|---|---|
| Total Calls | 58,400▼ 31.46% |
| Total Puts | 67,700▼ 59.99% |
Holdings and activity of institutional investors.
| Ownership % | 348.55%▲ 259.19% |
|---|---|
| Total Invested | $41.33M▼ 57.01% |
| Investors Holding | 34▼ 8.00% |
No data
Zepp Health's mission is to connect health with technology. Since its inception in 2013, the company has developed a platform of proprietary technology including AI chips, biometric sensors, and data algorithms, which drive a broadening ...